PTAB provides two step road map for securing companion diagnostic and other biomarker-based patents.
November 24, 2019
PTAB reverses Examiner’s decision that intrathecal dose would have been arrived at by “routine optimization”
November 19, 2019
PTAB reverses obviousness rejection based on unpredictable results from site of deuteration
November 04, 2019
PTAB reverses Examiner’s finding of obviousness based on evidence distinguishing claimed insomnia population from insomnia population in the prior art.
October 20, 2019
Rosy predictions of cancer drug’s efficacy in a general review article did not impart reasonable expectation of success without data supporting the predictions.
October 14, 2019
Pharmacokinetic / dissolution claims save sustained release combination of naltrexone and bupropion from generic challenge.
September 30, 2019
Federal Circuit reversed district court decision to dismiss patent lawsuit at pleadings stage because dose adjustment required by claims was concrete application of natural law.
September 02, 2019
FDA clarifies requirements to be listed as the active ingredient in a drug product.
January 06, 2019
When will a preamble to a claimed method of treatment be given limiting effect? The answer might surprise you.
November 27, 2018